Abstract
Background
A high hip center total hip arthroplasty (THA) for dysplasia allows more complete socket coverage by native bone at the expense of abnormal hip biomechanics. Despite poor results with cemented components, intermediate-term results with cementless cups at a high hip center have been promising, but there are few reports at long-term followup without bone graft.
Questions/purposes
The purpose of this study was to examine (1) survivorship; 2) radiographic results; and 3) hip scores at a minimum of 10 years for patients treated with high hip center cementless THA for Crowe II and III dysplasia without bone graft.
Methods
We reviewed charts and radiographs of 32 patients with Crowe II or III dysplasia who were treated with high hip center cementless THA; at a mean followup of 12 years (range, 10–21 years), 23 patients (27 hips) were available for review. We sought to medialize cups to the inner table to achieve bony coverage of > 75%. At final followup, the WOMAC and Harris hip scores were recorded. Radiographic analysis including computerized wear evaluation was performed. Radiographic parameters were compared with a control group of 23 patients with Crowe I dysplasia who had cementless cups placed at an anatomic hip center; among the high hip center reconstructions, we also compared wear between those in the superolateral and superomedial quadrants.
Results
Kaplan-Meier survivorship for all-cause revisions was 97% (95% confidence interval, 79%–99%) in the high hip center group; this was no different from the anatomic hip center group. There were no revisions for acetabular loosening. Wear rates did not differ significantly between the high hip center and the control group, but lateralized high hip centers were associated with higher (p = 0.002) wear. Hip scores were excellent in both groups.
Conclusions
In Crowe II and III dysplasia, a high hip center cementless cup obviates the need for bone graft and provides durable fixation beyond 10 years. Medialization of these reconstructions seems important to decrease wear.
Level of Evidence
Level III, therapeutic study. See Instructions for Authors for a complete description of levels of evidence.
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.References
Anderson MJ, Harris WH. Total hip arthroplasty with insertion of the acetabular component without cement in hips with total congenital dislocation or marked congenital dysplasia. J Bone Joint Surg Am. 1999;81:347–354.
Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol. 1988;15:1833–1840.
Brooker AF, Bowerman JW, Robinson RA, Riley LH Jr. Ectopic ossification following total hip replacement. Incidence and a method of classification. J Bone Joint Surg Am. 1973;55:1629–1632.
Callaghan JJ, Salvati EA, Pellicci PM, Wilson PD Jr, Ranawat CS. Results of revision for mechanical failure after cemented total hip replacement, 1979 to 1982. A two to five-year follow-up. J Bone Joint Surg Am. 1985;67:1074–1085.
Crowe JF, Mani VJ, Ranawat CS. Total hip replacement in congenital dislocation and dysplasia of the hip. J Bone Joint Surg Am. 1979;61:15–23.
DeLee JG, Charnley J. Radiological demarcation of cemented sockets in total hip replacement. Clin Orthop Relat Res. 1976;121:20–32.
Garvin KL, Bowen MK, Salvati EA, Ranawat CS. Long-term results of total hip arthroplasty in congenital dislocation and dysplasia of the hip. A follow-up note. J Bone Joint Surg Am. 1991;73:1348–1354.
Gerber SD, Harris WH. Femoral head autografting to augment acetabular deficiency in patients requiring total hip replacement. A minimum five-year and an average seven-year follow-up study. J Bone Joint Surg Am. 1986;68:1241–1248.
Hampton BJ, Harris WH. Primary cementless acetabular components in hips with severe developmental dysplasia or total dislocation. A concise follow-up, at an average of sixteen years, of a previous report. J Bone Joint Surg Am. 2006;88:1549–1552.
Harris WH. Traumatic arthritis of the hip after dislocation and acetabular fractures: treatment by mold arthroplasty. An end-result study using a new method of result evaluation. J Bone Joint Surg Am. 1969;51:737.
Harris WH, Crothers O, Oh I. Total hip replacement and femoral-head bone-grafting for severe acetabular deficiency in adults. J Bone Joint Surg Am. 1977;59:752–759.
Hendricks KJ, Harris WH. High placement of noncemented acetabular components in revision total hip arthroplasty. A concise follow-up, at a minimum of fifteen years, of a previous report. J Bone Joint Surg Am. 2006;88:2231–2236.
Johnston RC, Brand RA, Crowninshield RD. Reconstruction of the hip: a mathematical approach to determine optimum geometric relationships. J Bone Joint Surg Am. 1979;61:639–652.
Kaneuji A, Sugimori T, Ichiseki T, Yamada K, Fukui K, Matsumoto T. Minimum ten-year results of a porous acetabular component for Crowe I to III hip dysplasia using an elevated hip center. J Arthroplasty. 2009;24:187–194.
Maloney WJ, Galante JO, Anderson M, Goldberg V, Harris WH, Jacobs J, Kraay M, Lachiewicz P, Rubash HE, Schutzer S, Woolson ST. Fixation, polyethylene wear, and pelvic osteolysis in primary total hip replacement. Clin Orthop Relat Res. 1999;369:157.
Mulroy RD Jr, Harris WH. Failure of acetabular autogenous grafts in total hip arthroplasty. Increasing incidence: a follow-up note. J Bone Joint Surg Am. 1990;72:1536–1540.
Murayama T, Ohnishi H, Okabe S, Tsurukami H, Mori T, Nakura N, Uchida S, Sakai A, Nakamura T. 15-year comparison of cementless total hip arthroplasty with anatomical or high cup placement for Crowe I to III hip dysplasia. Orthopedics. 2012;35:313–318.
Pagnano MW, Hanssen AD, Lewallen DG, Shaughnessy WJ. The effect of superior placement of the acetabular component on the rate of loosening after total hip arthroplasty. J Bone Joint Surg Am. 1996;78:1004–1014.
Ranawat AS, Tsailis P, Meftah M, Koob TW, Rodriguez JA, Ranawat CS. Minimum 5-year wear analysis of first-generation highly cross-linked polyethylene in patients 65 years and younger. J Arthroplasty. 2012;27:354–357.
Ranawat CS, Dorr LD, Inglis AE. Total hip arthroplasty in protrusio acetabuli of rheumatoid arthritis. J Bone Joint Surg Am. 1980;62:1059–1065.
Russotti GM, Harris WH. Proximal placement of the acetabular component in total hip arthroplasty. A long-term follow-up study. J Bone Joint Surg Am. 1991;73:587–592.
Schutzer SF, Harris WH. High placement of porous-coated acetabular components in complex total hip arthroplasty. J Arthroplasty. 1994;9:359–367.
Shinar AA, Harris WH. Bulk structural autogenous grafts and allografts for reconstruction of the acetabulum in total hip arthroplasty. Sixteen-year-average follow-up. J Bone Joint Surg Am. 1997;79:159–168.
Acknowledgments
We thank Huong T. Do MA, for her assistance with the statistical analysis and Matin Lendhey BS, and Dhanasekara Raja MD, for assisting us with the data collection. Danyal H. Nawabi thanks the British Hip Society Charnley Latta Fund for supporting his fellowship training.
Author information
Authors and Affiliations
Corresponding author
Additional information
One of the authors certifies that he (ASR) or she, or a member of his or her immediate family, has or may receive payments or benefits, during the study period, an amount of less than USD 10,000 from DePuy (Warsaw, IN, USA), less than USD 100,000 from Conformis (Bedford, MA, USA), less than USD 10,000 from Convatec (Skillman, NJ, USA), and less than USD 100,000 from MAKO (Fort Lauderdale, FL, USA) and has ownership interest in Conformis. One of the authors certifies that he (CSR) or she, or a member of his or her immediate family, has or may receive payments or benefits, during the study period, an amount of less than USD 1,000,000 from DePuy and less than USD 1,000,000 from Stryker (Mahwah, NJ, USA).
All ICMJE Conflict of Interest Forms for authors and Clinical Orthopaedics and Related Research editors and board members are on file with the publication and can be viewed on request.
Clinical Orthopaedics and Related Research neither advocates nor endorses the use of any treatment, drug, or device. Readers are encouraged to always seek additional information, including FDA-approval status, of any drug or device prior to clinical use.
Each author certifies that his or her institution approved the human protocol for this investigation, that all investigations were conducted in conformity with ethical principles of research, and that informed consent for participation in the study was obtained.
About this article
Cite this article
Nawabi, D.H., Meftah, M., Nam, D. et al. Durable Fixation Achieved With Medialized, High Hip Center Cementless THAs for Crowe II and III Dysplasia. Clin Orthop Relat Res 472, 630–636 (2014). https://doi.org/10.1007/s11999-013-3187-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11999-013-3187-0